Induction of Endogenous Cytokines in Ascites of Patients with Ovarian Cancer by OK-432, A Streptococcal Preparation

Asia-Oceania Journal of Obstetrics and Gynaecology ◽

10.1111/j.1447-0756.1989.tb00190.x ◽

2010 ◽

Vol 15 (3) ◽

pp. 281-289 ◽

Author(s):

Hidehiro Mori ◽

Naoki Itoh ◽

Yoshitaka Yamada ◽

Teruhiko Tamaya

Keyword(s):

Ovarian Cancer ◽

Streptococcal Preparation

Download Full-text

Antitumor effect of the streptococcal preparation OK-432 in a murine model of ovarian cancer

Cancer Immunology Immunotherapy ◽

10.1007/bf00205596 ◽

1987 ◽

Vol 24 (2) ◽

Author(s):

Alan Lichtenstein

Keyword(s):

Ovarian Cancer ◽

Murine Model ◽

Antitumor Effect ◽

Streptococcal Preparation

Download Full-text

Mechanism of Induction of Endogenous Tumor Necrosis Factor in Ascites of Ovarian Cancer Patients by OK-432, A Streptococcal Preparation

Immunopharmacology and Immunotoxicology ◽

10.3109/08923978909082141 ◽

1989 ◽

Vol 11 (1) ◽

pp. 33-53 ◽

Author(s):

Hidehiro Mori ◽

Naoki Itoh ◽

Teruhiko Tamaya

Keyword(s):

Ovarian Cancer ◽

Tumor Necrosis Factor ◽

Cancer Patients ◽

Tumor Necrosis ◽

Streptococcal Preparation ◽

Necrosis Factor

Download Full-text

Impact of extended cycles of chemotherapy on survival outcome in recurrent epithelial ovarian cancer

Gynecologic Oncology ◽

10.1016/j.ygyno.2020.05.644 ◽

2020 ◽

Vol 159 ◽

pp. 346-347

Author(s):

W.Y. Hwang ◽

S.I. Kim ◽

M. Lee ◽

K. Kim ◽

J.H. No ◽

...

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Survival Outcome

Download Full-text

Experimental Drug Shows Activity Against Advanced Ovarian Cancer in Phase II Trial

Ob Gyn News ◽

10.1016/s0029-7437(07)70576-1 ◽

2007 ◽

Vol 42 (13) ◽

pp. 2

Author(s):

PATRICE WENDLING

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Ovarian Cancer ◽

Experimental Drug

Download Full-text

Oral Contraceptives May Prevent Ovarian Cancer

Skin & Allergy News ◽

10.1016/s0037-6337(08)70172-4 ◽

2008 ◽

Vol 39 (3) ◽

pp. 49

Author(s):

BRUCE K. DIXON

Keyword(s):

Ovarian Cancer ◽

Oral Contraceptives

Download Full-text

Treatment patterns by decade of life in elderly women (≥70 years of age) with ovarian cancer

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70325-7 ◽

2007 ◽

Vol 2007 ◽

pp. 76-78

Author(s):

J.T. Thigpen

Keyword(s):

Ovarian Cancer ◽

Elderly Women ◽

Treatment Patterns

Download Full-text

Addition of Epirubicin As a Third Drug to Carboplatin-Paclitaxel in First-Line Treatment of Advanced Ovarian Cancer: A Prospectively Randomized Gynecologic Cancer Intergroup Trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group and the Groupe d'Investigateurs Nationaux pour I'Etude des Cancers Ovariens

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70319-1 ◽

2007 ◽

Vol 2007 ◽

pp. 69-70

Author(s):

J.T. Thigpen

Keyword(s):

Ovarian Cancer ◽

Gynecologic Cancer ◽

Advanced Ovarian Cancer ◽

Study Group ◽

Line Treatment ◽

Cancer Study ◽

Cancer Study Group ◽

Intergroup Trial ◽

First Line Treatment

Download Full-text

Does Aggressive Surgery Only Benefit Patients With Less Advanced Ovarian Cancer? Results From an International Comparison Within the SCOTROC-1 Trial

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70316-6 ◽

2007 ◽

Vol 2007 ◽

pp. 66-67

Author(s):

J.T. Thigpen

Keyword(s):

Ovarian Cancer ◽

International Comparison ◽

Advanced Ovarian Cancer

Download Full-text

Toxicity reduction of adenovirus mediated thymidine kinase gene therapy for ovarian cancer and subsequent combination with topoisomerase inhibitors: Design of a clinical phase I study

Journal of the Society for Gynecologic Investigation ◽

10.1016/s1071-5576(97)86111-4 ◽

1998 ◽

Vol 5 (1) ◽

pp. 47A-47A ◽

Author(s):

X TONG ◽

D ENGEHAUSEN ◽

D SHINE ◽

I AGOULNIK ◽

T KIM ◽

...

Keyword(s):

Ovarian Cancer ◽

Gene Therapy ◽

Phase I ◽

Thymidine Kinase ◽

Phase I Study ◽

Thymidine Kinase Gene ◽

Topoisomerase Inhibitors ◽

Kinase Gene ◽

Clinical Phase ◽

Toxicity Reduction

Download Full-text

Risk assessment, early diagnosis and gene replacement therapy: p53 to attack current problems in the management of ovarian cancer

Journal of the Society for Gynecologic Investigation ◽

10.1016/s1071-5576(97)86110-2 ◽

1998 ◽

Vol 5 (1) ◽

pp. 47A-47A

Author(s):

I RUNNEBAUM ◽

S WANGGOHRKE ◽

E STICKEIER ◽

V MOEBUS ◽

H GRILL ◽

...

Keyword(s):

Ovarian Cancer ◽

Risk Assessment ◽

Early Diagnosis ◽

Replacement Therapy ◽

Gene Replacement ◽

Gene Replacement Therapy

Download Full-text